Bridge over troubled waters

Nature Medicine

Volumn 5, Issue 1, 1999, Pages 22-23

  Sariola, Hannu ^a   Philipson, Lennart ^b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; POLYCYSTIN;

GENE TARGETING; HUMAN; KIDNEY DEVELOPMENT; KIDNEY HYPOPLASIA; KIDNEY POLYCYSTIC DISEASE; NEPHROBLASTOMA; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS REGULATION; SHORT SURVEY; TREATMENT PLANNING; VON HIPPEL LINDAU DISEASE;

HUMANS; KIDNEY; KIDNEY DISEASES; MEMBRANE PROTEINS; MORPHOGENESIS; PROTEINS;

EID: 0033049139     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/4700     Document Type: Short Survey

References (8)

1. Kestila, M. et al. Positionally cloned gene for a novel glomerular protein, nephrin, is mutated in congenital nephrotic syndrome. Mol. Cell 1, 575-582 (1998)
2. Pugh J.L, Sweeney, W.E. Jr. & Avner, E.D. Tyrosine kinase activity of the EGF receptor in murine metanephric organ culture. Kidney Int. 47, 774-781 (1995).
3. Richards, W.G. et al. Epidermal growth factor receptor activity mediates renal cyst formation in polycystic kidney disease. J. clin. Invest. 101, 935-939 (1998).
4. Winyard, P.J., Risdon, R.A., Sams, V.R., Dressler, C.R. & Woolf, A.S. The PAX2 transcription factor is expressed in cystic and hyperproliferative dysplastic epithelia in human kidney malformations. J. Clin. Invest. 98, 451-459 (1996).
5. Rothenpieler, U.W. & Dressler, G.R. Pax-2 is required for mesenchyme-to-epithelium conversion during kidney development. Development 119, 711-720 (1993).
6. Veis, D.J., Sorenson, C.M., Shutter, J.R. & Korsmeyer, S.J. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys and hypopigmented hair. Cell 75, 229-240 (1994).
7. Sariola, H. & Sainio, K. The tip-top branching ureter. Curr. Opin. Cell Biol. 9, 877-884 (1997).
8. Fienberg, A.A. et al. DARPP-32: Regulator of the efficacy of dopaminergic neurotransmission. Science 281, 838-842 (1998).